|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-12-21
|
|
pubmed:abstractText |
There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1198-2241
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
581-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15611808-Bronchodilator Agents,
pubmed-meshheading:15611808-Canada,
pubmed-meshheading:15611808-Double-Blind Method,
pubmed-meshheading:15611808-Economics, Pharmaceutical,
pubmed-meshheading:15611808-Humans,
pubmed-meshheading:15611808-Multicenter Studies as Topic,
pubmed-meshheading:15611808-Outcome Assessment (Health Care),
pubmed-meshheading:15611808-Patient Selection,
pubmed-meshheading:15611808-Prospective Studies,
pubmed-meshheading:15611808-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:15611808-Randomized Controlled Trials as Topic,
pubmed-meshheading:15611808-Research Design,
pubmed-meshheading:15611808-Scopolamine Derivatives
|
|
pubmed:articleTitle |
The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment.
|
|
pubmed:affiliation |
The Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada. saaron@ottawahospital.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
